Trial Profile
A Study To Assess Clinical Utility Of The Drug Tolerant Assay For Vedolizumab (Anser VDZ) And Clinical Response To Vedolizumab In Patients With Inflammatory Bowel Disease In Clinical Practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 10 Jan 2017 New trial record